CT
IDXX icon

Colonial Trust’s Idexx Laboratories IDXX Stock Holding History

Colonial Trust’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.2K Hold
46
– – ﹤0.01% 648
2026
Q1 		$25.8K Sell
46
-12
-21% -$7.7K ﹤0.01% 635
2025
Q4 		$39.3K Sell
58
-3
-5% -$2.04K 0.01% 582
2025
Q3 		$39.1K Hold
61
– – 0.01% 585
2025
Q2 		$32.8K Buy
61
+6
+11% +$2.87K ﹤0.01% 596
2025
Q1 		$23.1K Sell
55
-30
-35% -$13K ﹤0.01% 664
2024
Q4 		$35.1K Buy
85
+39
+85% +$17.1K 0.01% 652
2024
Q3 		$23.5K Buy
46
+1
+2% +$486 ﹤0.01% 687
2024
Q2 		$22.2K Hold
45
– – ﹤0.01% 649
2024
Q1 		$24.3K Hold
45
– – ﹤0.01% 627
2023
Q4 		$25.1K Sell
45
-7
-13% -$3.29K 0.01% 601
2023
Q3 		$24.8K Buy
52
+17
+49% +$8.48K 0.01% 581
2023
Q2 		$17.3K Hold
35
– – ﹤0.01% 618
2023
Q1 		$17.3K Hold
35
– – ﹤0.01% 612
2022
Q4 		$14.4K Buy
+35
New +$13.6K ﹤0.01% 623

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Colonial Trust's IDXX Position: Q2 2026 in Review

Colonial Trust held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 46 shares worth $24.2K. The position accounts for ﹤0.01% of the portfolio, ranked #648.

Colonial Trust first reported a position in IDXX in Q4 2022 and has held it in 15 quarters since. The position peaked at $39.3K in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Colonial Trust held 46 shares of Idexx Laboratories worth $24.2K as of Q2 2026.
  • Colonial Trust left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Colonial Trust's portfolio in Q2 2026, its #648 holding.
  • Colonial Trust first reported a position in Idexx Laboratories in Q4 2022 and has held it in 15 quarters since.
  • Colonial Trust's Idexx Laboratories position peaked at $39.3K in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.